Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 06/12/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy.

Condition: Relapsed or Refractory Hairy Cell Leukemia (HCL)
Journal: Blood
Treatment Used: Vemurafenib
Number of Patients: 36
Published: August 05, 2022

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.

Condition: Hairy Cell Leukemia (HCL)
Journal: Blood cancer journal
Treatment Used: Cladribine
Number of Patients: 0
Published: July 19, 2022

Successful surgical resection of rectal cancer in a patient with relapsed hairy cell leukemia under interferon-α treatment.

Condition: Rectal Cancer
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Treatment Used: Surgical Resection
Number of Patients: 1
Published: January 13, 2022

A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma.

Journal: Current oncology (Toronto, Ont.)
Published: December 23, 2021

CD103-CD23+ classical hair cell leukemia: A case report and review of the literature.

Journal: Medicine
Published: December 23, 2021

CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.

Journal: Current oncology (Toronto, Ont.)
Published: December 23, 2021

How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen.

Journal: Current oncology (Toronto, Ont.)
Published: December 13, 2021

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.

Condition: Hairy-Cell Leukemia
Journal: The New England journal of medicine
Treatment Used: Vemurafenib plus Rituximab
Number of Patients: 30
Published: May 12, 2021

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.

Condition: Hairy Cell Leukemia
Journal: Journal of hematology & oncology
Treatment Used: Moxetumomab Pasudotox
Number of Patients: 80
Published: February 25, 2021

Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.

Condition: Hairy Cell Leukemia Variant
Journal: Medicine
Treatment Used: Rituximab plus Bendamustine
Number of Patients: 1
Published: February 17, 2021

Targeted therapy for treatment of patients with classical hairy cell leukemia.

Condition: Classical Hairy Cell Leukemia (cHCL)
Journal: Leukemia research
Treatment Used: Targeted Therapy
Number of Patients: 9
Published: February 14, 2021

How we treat mature B-cell neoplasms (indolent B-cell lymphomas).

Journal: Journal of hematology & oncology
Published: January 07, 2021
Showing 1-12 of 25

Last Updated: 06/12/2023